Trademark Overview
On Thursday, January 29, 2026, a trademark application was filed for GADOR with the United States Patent and Trademark Office. The USPTO has given the GADOR trademark a serial number of 99622920. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, June 4, 2026. This trademark is owned by Gador S.A.. The GADOR trademark is filed in the Pharmaceutical Products category with the following description:
Alginates for pharmaceutical purposes; Anti-cancer preparations; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of cardiovascular, hormonal, digestive, respiratory and central nervous system disorders; Pharmaceutical preparations for the treatment and prevention of heart rhythm disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for the prevention and treatment of cancer